Theranexus SA(DE:3VG)
€3.24+0.14 (+2.69%)
DE:3VG
Theranexus SA financials statements
€3.24
At close:+0.14 (+2.69%)
Theranexus SA (3VG) Ratios
0 Followers
Theranexus SA Ratios
DE:3VG's free cash flow for Q2 2026 was €9.80M. For the 2026 fiscal year, DE:3VG's free cash flow was decreased by €-151.36K and operating cash flow was €9.95M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.55 | 0.70 | 2.34 | 3.87 | 11.19 |
| Quick Ratio | 1.55 | 0.70 | 2.34 | 3.87 | 11.19 |
| Cash Ratio | 0.12 | 0.19 | 0.47 | 0.77 | 4.11 |
| Solvency Ratio | -0.38 | -0.31 | -1.31 | -0.99 | -1.04 |
| Operating Cash Flow Ratio | -0.15 | -0.92 | -2.49 | -1.98 | -4.66 |
| Short-Term Operating Cash Flow Coverage | -0.50 | -2.92 | -5.38 | -4.19 | -5.49 |
| Net Current Asset Value | € 1.57M | € -2.81M | € 950.96K | € 4.20M | € 8.31M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.27 | 0.77 | 0.50 | 0.41 | 0.32 |
| Debt-to-Equity Ratio | 1.45 | -1.73 | 1.64 | 0.85 | 0.52 |
| Debt-to-Capital Ratio | 0.59 | 2.36 | 0.62 | 0.46 | 0.34 |
| Long-Term Debt-to-Capital Ratio | 0.36 | 27.74 | 0.53 | 0.39 | 0.34 |
| Financial Leverage Ratio | 5.31 | -2.26 | 3.26 | 2.10 | 1.66 |
| Debt Service Coverage Ratio | -4.89 | -2.53 | -5.20 | -3.68 | -5.91 |
| Interest Coverage Ratio | -102.85 | -31.47 | -91.03 | -39.60 | -286.52 |
| Debt to Market Cap | 0.10 | 0.58 | 0.42 | 0.53 | 0.27 |
| Interest Debt Per Share | 0.22 | 0.35 | 0.48 | 0.95 | 1.09 |
| Net Debt to EBITDA | -0.21 | -0.85 | -0.33 | -0.47 | 0.02 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | -14.61% | -1565.37% | 19.98% | -1465443.52% |
| EBIT Margin | 0.00% | -115.02% | -2579.44% | -1508.17% | -1640470.76% |
| EBITDA Margin | 0.00% | -110.81% | -2492.90% | -1428.10% | -1440519.10% |
| Operating Profit Margin | 0.00% | -210.66% | -2579.44% | -1508.08% | -1580201.00% |
| Pretax Profit Margin | 0.00% | -110.94% | -2574.75% | -1731.99% | -1645986.05% |
| Net Profit Margin | 0.00% | -77.30% | -2304.16% | -1582.80% | -1353889.37% |
| Continuous Operations Profit Margin | 0.00% | -144.58% | -2304.16% | -1582.84% | -1353889.37% |
| Net Income Per EBT | 75.05% | 69.68% | 89.49% | 91.39% | 82.25% |
| EBT Per EBIT | 39.11% | 52.66% | 99.82% | 114.85% | 104.16% |
| Return on Assets (ROA) | -28.46% | -47.20% | -94.34% | -54.48% | -48.26% |
| Return on Equity (ROE) | -151.17% | 106.53% | -307.35% | -114.65% | -80.05% |
| Return on Capital Employed (ROCE) | -221.58% | -7762.50% | -163.25% | -67.04% | -61.18% |
| Return on Invested Capital (ROIC) | -120.30% | -396.13% | -116.64% | -53.86% | -46.89% |
| Return on Tangible Assets | -31.80% | -64.48% | -110.40% | -59.91% | -51.73% |
| Earnings Yield | -10.19% | -35.77% | -78.57% | -70.60% | -33.44% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 3.92 | 62.35 | 22.50 | 0.01 |
| Payables Turnover | 0.06 | 2.99 | 4.38 | 0.39 | 9.61 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 129.95 | 9.85 | 2.03 | 0.00 |
| Asset Turnover | 0.00 | 0.61 | 0.04 | 0.03 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 1.97 | 0.05 | 0.04 | 0.00 |
| Cash Conversion Cycle | -6275.05 | -29.16 | -77.43 | -923.93 | 25447.13 |
| Days of Sales Outstanding | 0.00 | 93.04 | 5.85 | 16.22 | 25485.12 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 6275.05 | 122.20 | 83.29 | 940.16 | 38.00 |
| Operating Cycle | 0.00 | 93.04 | 5.85 | 16.22 | 25485.12 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.06 | -0.39 | -0.82 | -1.01 | -1.27 |
| Free Cash Flow Per Share | -0.07 | -0.40 | -0.83 | -1.02 | -1.30 |
| Dividend Paid and CapEx Coverage Ratio | -15.77 | -102.95 | -145.80 | -130.37 | -41.49 |
| Capital Expenditure Coverage Ratio | -15.77 | -102.95 | -145.80 | -130.37 | -41.49 |
| Operating Cash Flow Coverage Ratio | -0.31 | -1.17 | -1.75 | -1.10 | -1.17 |
| Operating Cash Flow to Sales Ratio | 0.00 | -1.48 | -21.46 | -12.95 | -10381.31 |
| Free Cash Flow Yield | -3.19% | -68.94% | -73.67% | -58.22% | -26.26% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -9.73 | -2.80 | -1.27 | -1.42 | -2.99 |
| Price-to-Sales (P/S) Ratio | 0.00 | 2.16 | 29.32 | 22.42 | 40484.86 |
| Price-to-Book (P/B) Ratio | 14.83 | -2.98 | 3.91 | 1.62 | 2.39 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -31.33 | -1.45 | -1.36 | -1.72 | -3.81 |
| Price-to-Operating Cash Flow Ratio | -33.32 | -1.46 | -1.37 | -1.73 | -3.90 |
| Price-to-Earnings Growth (PEG) Ratio | -2.04 | 0.04 | 0.04 | 0.06 | -0.07 |
| Enterprise Value Multiple | -3.12 | -2.80 | -1.51 | -2.04 | -2.79 |
| Enterprise Value | 31.59M | 7.09M | 11.13M | 12.09M | 24.18M |
| EV to EBITDA | -3.12 | -2.80 | -1.51 | -2.04 | -2.79 |
| EV to Sales | 0.00 | 3.11 | 37.57 | 29.13 | 40164.67 |
| EV to Free Cash Flow | -33.61 | -2.08 | -1.74 | -2.23 | -3.78 |
| EV to Operating Cash Flow | -35.74 | -2.10 | -1.75 | -2.25 | -3.87 |
| Tangible Book Value Per Share | 0.13 | -0.31 | 0.15 | 0.87 | 1.84 |
| Shareholders’ Equity Per Share | 0.14 | -0.19 | 0.29 | 1.08 | 2.07 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.25 | -0.30 | 0.11 | 0.09 | 0.18 |
| Revenue Per Share | 0.00 | 0.27 | 0.04 | 0.08 | 0.00 |
| Net Income Per Share | -0.22 | -0.21 | -0.88 | -1.24 | -1.66 |
| Tax Burden | 0.75 | 0.70 | 0.89 | 0.91 | 0.82 |
| Interest Burden | 0.39 | 0.96 | 1.00 | 1.15 | 1.00 |
| Research & Development to Revenue | 0.00 | 1.17 | 25.45 | 9.46 | 9225.91 |
| SG&A to Revenue | 0.00 | 0.94 | 8.77 | 16.93 | 981.45 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.29 | 1.91 | 0.93 | 0.82 | 0.77 |
Currency in EUR
